Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor-beta. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein)
about
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activinMacrophages express osteopontin during repair of myocardial necrosisCharacterization of the promoter region of the porcine opn (osteopontin, secreted phosphoprotein 1) gene. Identification of positive and negative regulatory elements and a 'silent' second promoter.TGF beta 1 signaling and stimulation of osteoadherin in human odontoblasts in vitro.Secreted Protein Acidic and Rich in Cysteine in Ocular TissueOsteopontin: regulation in tumor metastasis.Transforming growth factor-beta 1 regulation of bone sialoprotein gene transcription: identification of a TGF-beta activation element in the rat BSP gene promoter.Osteopontin increases the expression of β1, 4-galactosyltransferase-I and promotes adhesion in human RL95-2 cells.Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway.Mechanical stimulation of osteopontin mRNA expression and synthesis in bone cell cultures.Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture.Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype.The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin.Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro.Novel markers for poor prognosis in head and neck cancer.TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype.Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis.
P2860
Q24612297-7876F178-C494-487B-9991-4277610E43D8Q24676436-E8A1E087-245A-408E-BCA5-99A3DDC890E5Q33228948-1BBF7AA1-B210-4EC0-92EF-FC4B15FA9326Q34165642-893A4876-39FF-4ABA-B352-67DB70EC3127Q36074007-C21170AD-F138-4E67-9DED-1CDF7F4EF2AFQ37020157-0615AD9B-3505-42D3-9362-131E6FD7CF76Q38344978-B6B3E912-F84A-477C-9566-430D816FD240Q39305553-62014A51-90A1-4B2B-8FC8-9C37807C7D45Q41087192-17345451-FAD8-4EA2-B189-63725CAA2D33Q41131777-D71C5ADF-C6EE-4FBE-942D-BAD99560C278Q42860208-99F60F62-12CE-4624-BCF6-47366F32B7DCQ43545497-297289DD-785C-4D1A-A9E1-717D4B3DA5E6Q44184044-780859C8-D337-4D1D-A474-B5707ECEF7FFQ46296895-95BB4FFD-FC9B-4764-8919-FE7B42F92AD1Q47908249-9B8E77B6-6C3A-4677-B404-AB39543B83BBQ52215250-C6BFC980-FA74-4A9C-BC3D-610B9CE8EBEDQ53198376-EAB55779-9278-4FB7-8505-66E69FFA0695
P2860
Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor-beta. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein)
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Regulation of transformation-s ...... acidic cysteine-rich protein)
@en
type
label
Regulation of transformation-s ...... acidic cysteine-rich protein)
@en
prefLabel
Regulation of transformation-s ...... acidic cysteine-rich protein)
@en
P2093
P2860
P356
P1433
P1476
Regulation of transformation-s ...... acidic cysteine-rich protein)
@en
P2093
Overall CM
P2860
P304
P356
10.1042/BJ2730523
P407
P478
273 ( Pt 3)
P577
1991-02-01T00:00:00Z